Sigma Ends Boots Bid as $10 Billion Pharmacy Deal Falls Apart
Sigma Healthcare has ended talks to buy Boots, walking away from a deal valued at about $10 billion and leaving the future of the U.K. pharmacy chain uncertain.
pharma
Read more
Johnson & Johnson to Buy Firefly Bio for $1 Billion to Expand Cancer Drug Pipeline
Johnson & Johnson will acquire Firefly Bio for $1 billion in cash, adding a new platform aimed at KRAS-driven tumors and strengthening its oncology pipeline.